TPTX Shares Outstanding History



Below is a table of the TPTX shares outstanding history going back to 4/17/2019:

Date TPTX Shares Outstanding
4/17/201927.76M
5/16/201931.20M
7/15/201931.34M
8/12/201921.59M
10/15/201935.85M
3/5/202035.92M
5/1/202035.93M
8/6/202042.17M
11/6/202048.17M
2/23/202148.98M
4/30/202149.15M
8/2/202149.41M
11/2/202149.48M
2/22/202249.62M
5/3/202249.67M
8/1/202250.07M

Also see: TPTX Market Cap History
TPTX YTD Return
TPTX Historical Shares Outstanding:
+19.62% CAGR
TPTX Historical Shares Outstanding: +19.62% CAGR

Mouse over chart for data details
4/17/2019 ...8/1/2022
Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing therapies that target genetic drivers of cancer. Co.'s main drug candidate, repotrectinib, is being evaluated for the treatment of patients with ROS1+ advanced non-small-cell lung cancer and patients with NTRK+ advanced solid tumors. Elzovantinib, Co.'s MET/SRC/CSF1R inhibitor, is being evaluated in its ongoing Phase 1 SHIELD-1 clinical trial, in patients with advanced solid tumors harboring genetic alterations in MET. Co.'s clinical trial of its RET inhibitor, TPX-0046 in patients with advanced solid tumors is ongoing. Co.'s fourth drug candidate, TPX-0131, is an ALK inhibitor. We show 16 historical shares outstanding datapoints in our coverage of TPTX's shares outstanding history.

Understanding the changing numbers of TPTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TPTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TPTX by allowing them to research TPTX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree TPTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Turning Point Therapeutics (TPTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

TRDA Shares Outstanding History
TRML Shares Outstanding History
TROV Shares Outstanding History
TRVI Shares Outstanding History
TRVN Shares Outstanding History
TSBX Shares Outstanding History
TSHA Shares Outstanding History
TSRO Shares Outstanding History
TSVT Shares Outstanding History
TTNP Shares Outstanding History
More Healthcare companies »

 

TPTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.